fox29.com
57%
365
What is bebtelovimab? US authorizes new antibody drug to fight omicron
A monoclonal treatment site located in a tent is closed for patients on January 25, 2022 in Sunrise, Florida. (Photo by Joe Raedle/Getty Images) WASHINGTON - U.S. health regulators on Friday authorized a new antibody drug that targets the omicron variant, a key step in restocking the nation's arsenal against the latest version of COVID-19.The Food and Drug Administration said it cleared the Eli Lilly drug for adults and adolescent patients with mild-to-moderate cases of COVID-19.